<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2020-03-19" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2020-03-19</h4>



<!--
%\VignetteEngine{knitr::rmarkdown}
%\VignetteIndexEntry{Guiding Oncology Dose-Escalation Trials}
-->
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(RBesT)  <span class="co">## defines logit function</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-4" title="4"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb4-5" title="5"></a>
<a class="sourceLine" id="cb4-6" title="6"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-7" title="7"></a>
<a class="sourceLine" id="cb4-8" title="8">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-9" title="9">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-12" title="12">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-13" title="13"></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-15" title="15"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-16" title="16"></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-18" title="18"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-19" title="19"></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-21" title="21"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-22" title="22"></a>
<a class="sourceLine" id="cb4-23" title="23"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-24" title="24"></a>
<a class="sourceLine" id="cb4-25" title="25">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-26" title="26">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-30" title="30"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-32" title="32">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-33" title="33">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-34" title="34">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-37" title="37">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-38" title="38">  ),</a>
<a class="sourceLine" id="cb4-39" title="39">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-40" title="40">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-44" title="44">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-45" title="45">  ),</a>
<a class="sourceLine" id="cb4-46" title="46">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-47" title="47">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-48" title="48">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-51" title="51">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-52" title="52">  ),</a>
<a class="sourceLine" id="cb4-53" title="53">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-54" title="54">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-55" title="55">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-58" title="58">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-59" title="59">  ),</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-68" title="68">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-71" title="71">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-74" title="74">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-76" title="76">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-77" title="77">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>expand_grid</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.067</td>
<td align="right">0.154</td>
<td align="right">0.000</td>
<td align="right">0.022</td>
<td align="right">0.655</td>
<td align="right">0.924</td>
<td align="right">0.030</td>
<td align="right">0.046</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.097</td>
<td align="right">0.166</td>
<td align="right">0.001</td>
<td align="right">0.049</td>
<td align="right">0.778</td>
<td align="right">0.888</td>
<td align="right">0.052</td>
<td align="right">0.060</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.137</td>
<td align="right">0.174</td>
<td align="right">0.002</td>
<td align="right">0.089</td>
<td align="right">0.844</td>
<td align="right">0.790</td>
<td align="right">0.136</td>
<td align="right">0.074</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.102</td>
<td align="right">0.185</td>
<td align="right">0.000</td>
<td align="right">0.036</td>
<td align="right">0.835</td>
<td align="right">0.847</td>
<td align="right">0.078</td>
<td align="right">0.075</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.167</td>
<td align="right">0.227</td>
<td align="right">0.005</td>
<td align="right">0.079</td>
<td align="right">0.940</td>
<td align="right">0.722</td>
<td align="right">0.139</td>
<td align="right">0.139</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.202</td>
<td align="right">0.239</td>
<td align="right">0.008</td>
<td align="right">0.108</td>
<td align="right">0.953</td>
<td align="right">0.630</td>
<td align="right">0.185</td>
<td align="right">0.184</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.249</td>
<td align="right">0.254</td>
<td align="right">0.010</td>
<td align="right">0.151</td>
<td align="right">0.963</td>
<td align="right">0.521</td>
<td align="right">0.222</td>
<td align="right">0.257</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.148</td>
<td align="right">0.205</td>
<td align="right">0.002</td>
<td align="right">0.080</td>
<td align="right">0.901</td>
<td align="right">0.756</td>
<td align="right">0.141</td>
<td align="right">0.104</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.218</td>
<td align="right">0.247</td>
<td align="right">0.009</td>
<td align="right">0.121</td>
<td align="right">0.958</td>
<td align="right">0.589</td>
<td align="right">0.207</td>
<td align="right">0.204</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.258</td>
<td align="right">0.267</td>
<td align="right">0.008</td>
<td align="right">0.151</td>
<td align="right">0.970</td>
<td align="right">0.518</td>
<td align="right">0.201</td>
<td align="right">0.282</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.309</td>
<td align="right">0.292</td>
<td align="right">0.008</td>
<td align="right">0.199</td>
<td align="right">0.981</td>
<td align="right">0.444</td>
<td align="right">0.192</td>
<td align="right">0.364</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.210</td>
<td align="right">0.225</td>
<td align="right">0.004</td>
<td align="right">0.137</td>
<td align="right">0.951</td>
<td align="right">0.564</td>
<td align="right">0.260</td>
<td align="right">0.176</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.283</td>
<td align="right">0.272</td>
<td align="right">0.010</td>
<td align="right">0.183</td>
<td align="right">0.977</td>
<td align="right">0.460</td>
<td align="right">0.220</td>
<td align="right">0.320</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.326</td>
<td align="right">0.300</td>
<td align="right">0.007</td>
<td align="right">0.216</td>
<td align="right">0.986</td>
<td align="right">0.428</td>
<td align="right">0.186</td>
<td align="right">0.386</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.372</td>
<td align="right">0.329</td>
<td align="right">0.005</td>
<td align="right">0.268</td>
<td align="right">0.992</td>
<td align="right">0.390</td>
<td align="right">0.161</td>
<td align="right">0.449</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the modelâ€™s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.191</td>
<td align="right">0.16</td>
<td align="right">0.02</td>
<td align="right">0.142</td>
<td align="right">0.637</td>
<td align="right">0.554</td>
<td align="right">0.287</td>
<td align="right">0.158</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.265</td>
<td align="right">0.20</td>
<td align="right">0.03</td>
<td align="right">0.210</td>
<td align="right">0.785</td>
<td align="right">0.379</td>
<td align="right">0.329</td>
<td align="right">0.292</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.445</td>
<td align="right">0.256</td>
<td align="right">0.065</td>
<td align="right">0.407</td>
<td align="right">0.934</td>
<td align="right">0.149</td>
<td align="right">0.250</td>
<td align="right">0.601</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.526</td>
<td align="right">0.264</td>
<td align="right">0.086</td>
<td align="right">0.519</td>
<td align="right">0.973</td>
<td align="right">0.089</td>
<td align="right">0.195</td>
<td align="right">0.716</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      RBesT_1.4-0      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.6-3 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.2       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       withr_2.1.2        glue_1.3.1        
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] mvtnorm_1.0-11     codetools_0.2-16   evaluate_0.14     
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    highr_0.8         
## [31] rstantools_2.0.0   scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.0 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] tibble_2.1.3       Formula_1.2-3      crayon_1.3.4      
## [49] pkgconfig_2.0.3    zeallot_0.1.0      ellipsis_0.3.0    
## [52] prettyunits_1.0.2  ggridges_0.5.1     assertthat_0.2.1  
## [55] rmarkdown_1.16     R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
